THE MENOPAUSE - HEALTH IMPLICATIONS AND CLINICAL MANAGEMENT

被引:86
作者
GREENDALE, GA [1 ]
JUDD, HL [1 ]
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, DIV REPROD ENDOCRINOL, LOS ANGELES, CA USA
关键词
D O I
10.1111/j.1532-5415.1993.tb06953.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To review the anatomy, physiology, clinical symptoms, long-term health effects, and treatment of the menopause and climacteric syndrome, with a special emphasis on features, such as incontinence, particularly relevant to geriatric medicine. Data sources: English-language publications on menopause and the climacteric. Study selection: Articles and books containing recent information pertinent to the topics covered. Studies in human subjects were given priority, but primate studies that amplify physiologic concepts are included. Data synthesis: Due to increased longevity, the average US woman will spend one-third of her life as a postmenopausal individual. Anatomic and physiologic changes associated with the peri- and postmenopausal state include hot flushes, genitourinary atrophy, and bone loss. Possible correlates of the menopausal transition and postmenopause include affective changes and unfavorable alterations in lipoproteins and other cardiac risk factors. Clinical correlates of these changes can include incontinence, sexual dysfunction, increased risk of fracture, dysphoric mood, and increased risk of cardiovascular disease. Formal indications for estrogen therapy are hot flushes, genital atrophy, and osteoporosis prevention; other common clinical uses are reviewed. Non-contraceptive estrogens can be administered orally, transdermally, vaginally, or by injection. Each route and preparation has some unique features with respect to actions and side effects. Progestins, in adequate doses, protect against the unwanted side effect of endometrial hyperplasia; alternatives to progestin use are presented. Non-hormonal alternatives for some peri- and postmenopausal symptoms are described. Conclusions: A discussion of the menopause and the benefits and risks of hormone therapy should be part of the routine health care of older women. Since the use of hormone therapy is elective, health care providers must elicit the goals, needs, and preferences of each patient, supply her with relevant information, and serve as a facilitator of her individual decision.
引用
收藏
页码:426 / 436
页数:11
相关论文
共 140 条
[1]   INHIBITION OF CORONARY-ARTERY ATHEROSCLEROSIS BY 17-BETA ESTRADIOL IN OVARIECTOMIZED MONKEYS - LACK OF AN EFFECT OF ADDED PROGESTERONE [J].
ADAMS, MR ;
KAPLAN, JR ;
MANUCK, SB ;
KORITNIK, DR ;
PARKS, JS ;
WOLFE, MS ;
CLARKSON, TB .
ARTERIOSCLEROSIS, 1990, 10 (06) :1051-1057
[2]   ESTROGEN THERAPY AFTER THE MENOPAUSE - BOON OR BANE [J].
ARMSTRONG, BK .
MEDICAL JOURNAL OF AUSTRALIA, 1988, 148 (05) :213-214
[3]  
BACHMANN GA, 1988, GERIATRICS, V43, P79
[4]   RISKS AND BENEFITS OF REPLACEMENT ESTROGEN [J].
BARRETTCONNOR, E .
ANNUAL REVIEW OF MEDICINE, 1992, 43 :239-251
[5]   ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN [J].
BARRETTCONNOR, E ;
BUSH, TL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14) :1861-1867
[6]   ISCHEMIC-HEART-DISEASE RISK IN POSTMENOPAUSAL WOMEN - EFFECTS OF ESTROGEN USE ON GLUCOSE AND INSULIN LEVELS [J].
BARRETTCONNOR, E ;
LAAKSO, M .
ARTERIOSCLEROSIS, 1990, 10 (04) :531-534
[7]   POSTMENOPAUSAL ESTROGEN AND PREVENTION BIAS [J].
BARRETTCONNOR, E .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :455-456
[8]   POSTMENOPAUSAL ESTROGEN REPLACEMENT AND BREAST-CANCER [J].
BARRETTCONNOR, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :319-320
[9]  
BEISLAND HO, 1984, UROL INT, V3911, P21184
[10]  
BERGMAN A, 1987, MENOPAUSE PHYSL PHAR, P67